Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like insider Michael Rapp added a total 100,000 shares to his position 10/19-10/23. Here's his transaction history and total shares owned:
http://www.insiderinsights.com/insider/1405685/rapp-michael
Bored bored. We're just waiting for more catalysts at this point, potentially months away.
Here's some incredibly uplifting news major investor Michael Rapp bought like 45k shares just last Thursday and another 27k just yesterday. Bought in at the upper $9s.
https://www.dispatchtribunal.com/2017/10/24/zynerba-pharmaceuticals-inc-zyne-major-shareholder-michael-rapp-purchases-25745-shares-of-stock.html
Volume is insanely low the last couple of days... like pre- positive news low. Is it being manipulated less or something?
Where is our goddamn revaluation into the teens. It's worth it. Do we seriously have to wait until December for a real pop??
Can anyone refer me to where I could possibly see the live percentage of short interest and other miscellaneous live data?
Anyone got a happy interpretation of the movement of this week?
I'm feeling kind of deflated about getting to $12s this month.
That's a great pdf they released! Updates on all pipelines and progress.
Zack's upgraded today:
https://transcriptdaily.com/2017/10/12/zacks-investment-research-upgrades-zynerba-pharmaceuticals-inc-zyne-to-buy.html
Thank god for today's rebound. It supports the overall upward trend. It seems like we found support first at around $8.35 and then around $9.35. That latest support was tested at market open, then we ran up as much as we could and now support is being tested at around $9.80 - $10.00.
Hopefully we'll see consolidation at $10.00 and an upward move toward $11s by Friday. Hopefully.
Ugh, this run down is a drag. I was hoping we'd open strong after Thur/Fri positioning. Is sentiment really still this shaky or am I just being impatient?
This stock was down in value for so long - I think shakeouts are bound to happen for various reasons:
Shorts are slowly, slowly being squeezed out. It fell a long way on the bad news - that's a lot of range for shorting that is being sorted out now.
People who are tired of the stress are getting out with minimized or reversed losses. These buyers are being replaced, but it's eating up some of the momentum.
------
I would also like to see another piece of good news from ZYNE as just one current catalyst for revaluation is having a hard time driving growth in the face of the two failures.
Long term prospects for ZYNE are gold though. If we get a good December update and success from either of the THC patch trials there isn't much left to hold ZYNE back. That's when a pre-commercialization value of $25 is realistic, I think.
In the meantime, fingers crossed for a reasonable climb to the $12's by end of next week.
Kicking myself for not putting up the last of my funds at $8.60 yesterday or todays open.
Escalator step 1: $8.80. step 2: $9.00.
Step 10: $10.60
And off we go! Probably last chance buy in for anyone that has hesitated thus far.
Here is the link for the Cantor Fitz upgrade:
https://www.streetinsider.com/dr/news.php?id=13346899&gfv=1
Also, it appears the value is consolidating at mid $8s. The 5 day chart is showing the downward slope as leveling out between last Friday afternoon and today. Hopefully this the first real sign the shorts are losing control.
It's linked through the stock app I use. I also googled it for a better source and it's appearing on the analyst estimates readout here on InvestorHub.
Cantor Fitzgerald just upgraded rating from Neutral to Overweight.
Are analyst updates expected to be published today?